| NDC Code | 0591-3332-19 |
|---|
| Package Description | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3332-19) |
|---|
| Product NDC | 0591-3332 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bupropion Hydrochloride |
|---|
| Proprietary Name Suffix | Xl |
|---|
| Non-Proprietary Name | Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20070613 |
|---|
| End Marketing Date | 20150731 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA077715 |
|---|
| Manufacturer | Actavis Pharma, Inc. |
|---|
| Substance Name | BUPROPION HYDROCHLORIDE |
|---|
| Strength | 300 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
|---|